Faheem Hadi

Dr. Faheem Hadi

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2024 in Journal of Health and Rehabilitation Research
Verified
Journal Article
Open access
PDF file
MZMemoona Zahra
Memoona Zahra
FHFaheem Hadi
Faheem Hadi
TMTahir Maqbool
Tahir Maqbool
HSHumaira Sultana
Humaira Sultana
FAFarah Abid
Farah Abid
MHMuhammad Qideer Ul Hassan
Muhammad Qideer Ul Hassan
Background: Curcumin, a compound derived from the turmeric plant (Curcuma longa), has been historically used in Asian cuisine and traditional medicine. It is known for its anti-inflammatory and antioxidant properties and is believed to have therapeutic potential in various inflammatory and oxidative conditions. However, concerns have emerged regarding its safety at higher doses, particularly its potential carcinogenic, reproductive, and hepatotoxic effects. Objective: The objective of this review was to evaluate the potential adverse effects of curcumin, focusing on its carcinogenic, reproductive, and hepatotoxic properties, as well as general side effects observed at different dosages. Methods: A comprehensive search was conducted using electronic databases such as PubMed, Scopus, and Web of Science to identify peer-reviewed articles published up to the date of this review. The search terms included "curcumin," "turmeric," "carcinogenic," "miscarriage," "hepatotoxicity," and related keywords. Studies were included if they investigated the biological effects of curcumin in vitro, in vivo, and in clinical settings, specifically addressing its adverse effects. Data were extracted on study design, sample size, dosage, duration of curcumin administration, observed adverse effects, and conclusions. Quality assessment of the studies was performed using standardized tools appropriate for different study designs. The data were synthesized qualitatively and presented in a narrative format, with tables summarizing key characteristics and results. Results: The review included numerous studies that reported adverse effects of curcumin at higher doses. Curcumin was found to cause DNA damage and chromosomal aberrations at doses of 10 µg/mL in vitro (1), and impaired tumor suppressor p53 function in colon cancer cells (2). Reproductive toxicity was observed with significant decreases in sperm motility, capacitation, and fertilization rates at concentrations of 5-50 µM (3). Embryo mortality in zebrafish occurred at 7.5 µM and 12.5 µM (4). Hepatotoxicity was reported in clinical cases of severe hepatitis linked to curcumin intake (7), and animal studies showed liver toxicity at dietary levels exceeding 30% turmeric (8). General side effects included gastrointestinal disturbances at doses of 900 to 3600 mg/day (9). Conclusion: While curcumin has beneficial anti-inflammatory and antioxidant properties, its use at higher doses poses significant risks, including DNA damage, reproductive toxicity, and hepatotoxicity. These findings underscore the necessity for cautious use of curcumin, particularly in high doses and over extended periods. Future research should focus on long-term studies to establish a comprehensive benefit-risk profile for curcumin.

3 May 2023 in International Journal of Applied and Experimental Biology
Verified
Journal Article
Open access
PDF file
IAIshfaq Ahmad
Ishfaq Ahmad
TMTahir Maqbool
Tahir Maqbool
SNSadia Naz
Sadia Naz
IUInam Ullah
Inam Ullah
FHFaheem Hadi
Faheem Hadi
MAMuhammad Atif
Muhammad Atif
Natural compounds having apoptotic effects are a new potential source for anti-cancer drugs. Numerous plant phytochemicals have proven anti-cancer properties by inducing programmed cell death (apoptosis). The disease known as cancer is characterized by the uncontrollable growth of some body cells and their spread to other body regions. Worldwide, cancer is a major cause of death. The objective of the current study was to assess apoptotic potential of geranyl acetate on HepG2 cancer cell line. Cell death and cell viability in groups were assessed using the MTT, trypan blue and crystal violet to assess anti-proliferative effect. P53 ELISA was carried out to assess apoptosis. When HepG2 cells were exposed to geranyl acetate they exhibited increased cytotoxicity, decreased viability, proliferation, and increased apoptosis. It is concluded that geranyl acetate has the potential to cause apoptosis via P53 in HepG2 cells. It can also prevent cancer cell growth and proliferation.

25 January 2024
Verified
Journal Article
Open access
PDF file
KWKashif Waqas
Kashif Waqas
ZNZeeshan Haider Naqvi
Zeeshan Haider Naqvi
UBUsama Basirat
Usama Basirat
MAMuhammad Usama Arshad
Muhammad Usama Arshad
JQJaved Anver Qureshi
Javed Anver Qureshi
FHFaheem Hadi
Faheem Hadi
The Hepatitis C virus is RNA containing virus which damages liver at molecular level and causes inflammatory conditions such as fibrosis and cirrhosis and can also lead to cancer. Various direct-acting anti-viral drugs available in local area were administered to patients. These drugs work on principle by targeting specific proteins which damage the virus. Many drugs are administered in combination and produce a sustained virological response in 12 weeks. A follow-up research was performed to evaluate 3 months of treatment outcome of some direct-acting antiviral drugs in 131 patients (110 patients of HCV genotype 3) above 50 years using relevant biological parameters. 115 patients yielded a pooled SVR of more than 85% after twelve weeks of commonly used antiviral drug evaluation. Commonly used antiviral drugs in Sialkot, Pakistan, showed effectiveness in HCV patients having genotypes 1-5 as evidenced by biological and haemotological markers.

25 January 2024
Verified
Journal Article
Open access
PDF file
KWKashif Waqas
Kashif Waqas
ZNZeeshan Haider Naqvi
Zeeshan Haider Naqvi
MAMuhammad Usama Arshad
Muhammad Usama Arshad
UBUsama Basirat
Usama Basirat
JQJaved Anver Qureshi
Javed Anver Qureshi
QAQurban Ali
Qurban Ali
The Hepatitis C virus contains RNA as its genome that can cause liver injury at the cellular level. Inflammation caused by viruses can progress to lethal conditions such as fibrosis, cirrhosis and cancer. Various direct-acting anti-viral drugs are available in the market in many regions of the world. These drugs work on principle by targeting specific proteins which damage the virus. Many drugs are administered in combination and produce a sustained virological response in 12 weeks. A follow-up research was performed to evaluate 3 months of treatment outcome of some direct-acting antiviral drugs in 131 patients (110 patients of HCV genotype 3) above 50 years and they were compared related to type of genotypes, administration of antiviral drugs, gender and age differences. 115 patients yielded a pooled SVR of more than 85% after twelve weeks of commonly used antiviral drug evaluation. Commonly used antiviral drugs in Sialkot, Pakistan, showed effectiveness in HCV patients having genotypes 1-5.